Deborah Grayson, a top pharmacist and nutritional therapist, has warned that weight loss medication can cause an inflamed ...

Compounded GLP-1s have given rise to a cottage industry offering cheaper weight loss medications to many Americans — but now ...

Tirzepatide — a drug that acts both as a GLP-1 agonist and a GIP agonist — is the active ingredient in an even more powerful ...

AbbVie Inc. enters the obesity market with GUBamy, a promising amylin analog. Click here to find out why ABBV stock is a Buy.

To be a person in the year 2025 is to encounter, in one way or another, the marketing onslaught for compounded ...

Gill Riley, from Warrington, Cheshire, started using the weight-loss injections, which work by mimicking hormones that ...

WALKING into the WeightWatchers meeting with her mum, then-eight-year-old Sarah Le Brocq was wide-eyed. It was 1990 and she ...

When best friends AnnaLee Canario and Dacia Benjamin started taking weight loss drugs together they thought it would be an ...

Compounded versions of popular drugs used for weight loss including Wegovy and Zepbound will soon no longer be available ...

A real-world study of over 4,000 US patients without type 2 diabetes found that those who persisted with Tirzepatide for at ...

Both semaglutide and tirzepatide should help people with Type 2 diabetes lower their HbA1c, a measure of blood glucose over ...

Despite the promising results, further research is needed before GLP-1 receptor agonists and dual GIP/GLP-1 receptor agonists ...